1. Home
  2. VRAX vs BGLC Comparison

VRAX vs BGLC Comparison

Compare VRAX & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$2.40

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$1.39

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
BGLC
Founded
2013
2017
Country
United Kingdom
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
4.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
VRAX
BGLC
Price
$2.40
$1.39
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 30.1K
3.2K
Earning Date
06-12-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.78
EPS
★ N/A
N/A
Revenue
N/A
★ $7,424,911.00
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.10
$1.07
52 Week High
$13.19
$5.85

Technical Indicators

Market Signals
Indicator
VRAX
BGLC
Relative Strength Index (RSI) 41.64 40.39
Support Level $0.18 $1.34
Resistance Level $3.01 $1.61
Average True Range (ATR) 0.19 0.08
MACD -0.01 -0.00
Stochastic Oscillator 32.26 32.70

Price Performance

Historical Comparison
VRAX
BGLC

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: